A healthy upside potential exists for ProPhase Labs Inc (PRPH) Stock

H.C. Wainwright raised the price target for the ProPhase Labs Inc (NASDAQ:PRPH) stock to “a Buy”. The rating was released on December 20, 2021, according to finviz. The research report from Dawson James has initiated the stock to Buy, with a price target set at $25. The latest trade, Performances and Moving Averages give us […]